Journals / Turkish Journal of Gastroenterology / 2014 / Cilt: 25 - Sayı: 4

The Turkish version of the Rome III criteria for IBS is valid and reliable COLON

Pages
386–392
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In this study, the internal consistency of the Rome III criteria for diagnosis of patients with IBS in our country was found to be an important criterion because of the fact that the Rome III criteria have high internal consistency and validation, they are a reliable measurement tool, they are able to distinguish IBS-positive and -negative cases with the same rate as a specialist and their application is very easy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: In this study, we aimed to provide the usage of the Rome III criteria for irritable bowel syndrome (IBS) in the healthcare field by conducting validity and reliability studies in Turkey and to facilitate diagnosis of these patients.Materials and Methods: Item analysis of the Rome III criteria was performed, and the test was applied to 79 patients after their consistency had been validated with expert opinion.
📊
Key Findings & Data:After the first application, the retest was applied to 77 cases, and the consistency between the two applications was examined by kappa analysis.
💡
Conclusion & Impact:Conclusion: In this study, the internal consistency of the Rome III criteria for diagnosis of patients with IBS in our country was found to be an important criterion because of the fact that the Rome III criteria have high internal consistency and validation, they are a reliable measurement tool, they are able to distinguish IBS-positive and -negative cases with the same rate as a specialist and their application is very easy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Background/Aims: In this study, we aimed to provide the usage of the Rome III criteria for irritable bowel syndrome (IBS) in the healthcare field by conducting validity and reliability studies in Turkey and to facilitate diagnosis of these patients.Materials and Methods: Item analysis of the Rome III criteria was performed, and the test was applied to 79 patients after their consistency had been validated with expert opinion. After the first application, the retest was applied to 77 cases, and the consistency between the two applications was examined by kappa analysis. IBS was diagnosed by expert opinion, which was accepted as ’the gold standard’.Results: Cronbach’s alpha of the Rome III criteria was calculated as 0.90. When the compliance between expert assessment and IBS Rome III diagnostic criteria was compared, the diagnostic criteria’s sensitivity was determined as 78.6%, and their specificity was 82.9%. When the Rome III criteria test-retest agreement was analysed, the sensitivity, specificity and negative and positive predictive values of the Rome III diagnostic criteria were determined as 97.4%. Conclusion: In this study, the internal consistency of the Rome III criteria for diagnosis of patients with IBS in our country was found to be an important criterion because of the fact that the Rome III criteria have high internal consistency and validation, they are a reliable measurement tool, they are able to distinguish IBS-positive and -negative cases with the same rate as a specialist and their application is very easy

🔖

Cite This Article

URAN, B. N. Ö., VARDAR, R., KARADAKOVAN, A., BOR, S. (2014). The Turkish version of the Rome III criteria for IBS is valid and reliable COLON. Turkish Journal of Gastroenterology, Cilt: 25 - Sayı: 4, 386–392. https://ajindex.com/articles/409620

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. Camilleri M, Spiller RC. Irritable bowel syndrome: Diagnosis and treatment. Melih Ozel, editors. İstanbul: Acar Press; 2006
  2. Nobaek S, Johansson ML, Molin G, Ahrné S, Jeppsson B. Alteration of intestinal micloflora is associated with reduction in abdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95; 1231-8. [CrossRef] 3. Dagli U. Irritable bowel syndrome: Diagnostic criteria and diagnostic methods. Available from: http://www.motilite.org.tr. Accessed December 12, 2011
  3. Uslan MI. Characteristics of gastric inflammation diagnosed patients with functional dyspepsia according to Rome III criteria. Master Thesis. Afyon Kocatepe University Faculty of Medicine. 2008
  4. Celik AF, Pamuk ON. Irritable bowel syndrome. Current gastroenterology and hepatology. İstanbul: Medical Scientific Publishing; 2001.p.228-41
  5. Olden KW. Treatment of irritable bowel syndrome: New modalities for a new millennium. Am J Gastroenterol 2000; 95: 863-4. [CrossRef] 7. Ozcelik H. Frequency of irritable bowel syndrome and relationship with lactose intolerance. Unpublished Master’s Thesis. Afyon Kocatepe University, Institution of Health Science, Department of Internal Medicine Nursing. 2004; 5-29
  6. Parlar S. Assessing the Quality of Life in Patients with irritable bowel syndrome. Unpublished Master’s Thesis. Gaziantep University, Institution of Health Science, Department of Internal Medicine Nursing. 2004; 1-32
  7. Yurtsever S. Fatigue in chronic illness and nursing care. Journal of Cumhuriyet University Nursing School. 2000; 4: 16-20
  8. Yakut K, et al. The effects of ırritable bowel syndrome quality of life in health care personnel and students. Available at: http://www. bayar.edu.tr. Accessed September 20, 2011 11. Ercan I, Kan I. The reliability and the validity at scales. The Journal of Uludağ University Faculty of Medicine 2004; 30; 211-6
  9. Molinder HKM, Kjellstrom L, Nylin HBO, Agreus LE. Doubtful outcome of the validation of the Rome II questionnaire: Validation of a symptom based diagnostic tool. Health Qual Life Outcomes 2009, 7: 106. [CrossRef] 13. Cash, BD, Chey, WD. Irritable bowel syndrome - An evidencebased approach to diagnosis. Aliment Pharmacol Ther 2004; 19: 1235-45. [CrossRef] 14. Sorouri M, Pourhoseingholi MA, Vahedi M, et al. Functional bowel disorders in Iranian population using Rome III criteria. Saudi J Gastroenterol 2010; 16: 154-60. [CrossRef] 15. Chang L. From Rome to Los Angeles-The Rome III criter